Timing of bolus in children with type 1 diabetes using continuous subcutaneous insulin infusion (TiBoDi Study)

Diabetes Technology and Therapeutics

Volumn 12, Issue 2, 2010, Pages 149-152

  Scaramuzza, Andrea E ^a   Iafusco, Dario ^b   Santoro, Laura ^a   Bosetti, Alessandra ^a   De Palma, Alessandra ^a   Spiri, Daniele ^a   Mameli, Chiara ^a   Zuccotti, Gian Vincenzo ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN ASPART;

ADOLESCENT; AREA UNDER THE CURVE; ARTICLE; BODY MASS; BOLUS INJECTION; CHILD; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTINUOUS INFUSION; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; INSULIN PUMP; INSULIN SENSITIVITY; MALE; MEAL; PATIENT MONITORING; POSTPRANDIAL STATE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

ADOLESCENT; AREA UNDER CURVE; BLOOD GLUCOSE; CHILD; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; INSULIN; INSULIN INFUSION SYSTEMS; MALE; TIME FACTORS; YOUNG ADULT;

EID: 76449086351     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/dia.2009.0117     Document Type: Article

References (13)

1. Bonora E, Corrao G, Bagnardi V, Ceriello A, Comaschi M, Montanari P, Meigs JB: Prevalence and correlates of postprandial hyperglycaemia in a large sample of patients with type 2 diabetes mellitus. Diabetologia 2006;49:846-854.
2. Dunn TC, Rebrin K, Peyser TA: Increased postprandial hyperglycemia due to rising preprandial glucose: results from a 40-day home use study using the Free-Style Navigator continuous glucose monitoring system . Diabetologia 2007; 50(Suppl 1):S116.
3. Ceriello A: Postprandial hyperglycemia and diabetes complications: is it time to treat? Diabetes 2005;54:1-7.
4. Niskanen L, Turpeinen A, Penttila I, Uusitupa MI: Hyperglycemia and compositional lipoprotein abnormalities as predictor of cardiovascular mortality in type 2 diabetes: a 15- year follow-up from the time of diagnosis. Diabetes Care 1998;21:1861-1869.
5. Battelino T, Ursic-Bratina N, Bratanic N, Zerjav-Tansek M, Avbelj M, Krzisnik C: The use of continuous subcutaneous insulin infusion (CSII) as the treatment of choice in children and adolescents with Type 1 diabetes. Pediatr Endocrinol Rev 2004;1(Suppl 3):537-539.
6. Eugster EA, Francis G; Lawson-Wilkins Drug and Therapeutics Committee: Position statement: continuous subcutaneous insulin infusion in very young children with type 1 diabetes. Pediatrics 2006;118:e1244-e1249.
7. Rutledge KS, Chase HP, Klingensmith GJ, Walravens PA, Slover RH, Garg SK: Effectiveness of postprandial Humalog in toddlers with diabetes. Pediatrics 1997;100:968-972.
8. Ceriello A, Colagiuri S, Gerich J, Tuomilehto J; Guideline Development Group: Guideline for management of postmeal glucose. Nutr Metab Cardiovasc Dis 2008;18:S17-S33.
9. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the Diabetes Control and Complications Trial. Diabetes 1995;44:968-983.
10. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998;352:837-853.
11. Ceriello A, Colagiuri S: Guidelines for management of postmeal blood glucose. Diabetes Voice 2007;52:9-11.
12. Bode BW: Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections. Clin Ther 2007;29(Suppl D):S135-S144.
13. Pinelli L, Rabbone I, Salardi S, Toni S, Scaramuzza A, Bonfanti R, Cherubini V, Franzese A, Frongia AP, Iafusco D, Sulli N, Tumini S, Curto O, Massimelli M; Diabetes Study Group of Italian Society of Paediatric Endocrinology and Diabetology: Insulin pump therapy in children and adolescents with type 1 diabetes: the Italian viewpoint. Acta Biomed 2008;79:57-65.